NO993647D0 - Endotelinantagonist - Google Patents

Endotelinantagonist

Info

Publication number
NO993647D0
NO993647D0 NO993647A NO993647A NO993647D0 NO 993647 D0 NO993647 D0 NO 993647D0 NO 993647 A NO993647 A NO 993647A NO 993647 A NO993647 A NO 993647A NO 993647 D0 NO993647 D0 NO 993647D0
Authority
NO
Norway
Prior art keywords
endothelin antagonist
endothelin
antagonist
keto
dihalo
Prior art date
Application number
NO993647A
Other languages
English (en)
Other versions
NO993647L (no
NO328460B1 (no
Inventor
Ryuji Ueno
Original Assignee
R Tech Ueno Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by R Tech Ueno Ltd filed Critical R Tech Ueno Ltd
Publication of NO993647D0 publication Critical patent/NO993647D0/no
Publication of NO993647L publication Critical patent/NO993647L/no
Publication of NO328460B1 publication Critical patent/NO328460B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A61K31/5575—Eicosanoids, e.g. leukotrienes or prostaglandins having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO19993647A 1997-11-28 1999-07-27 Anvendelse av 15-keto-prostaglandin E-forbindelser til fremstilling av medikamenter NO328460B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP32783297 1997-11-28
PCT/JP1998/005143 WO1999027934A1 (fr) 1997-11-28 1998-11-16 Antagoniste d'endotheline

Publications (3)

Publication Number Publication Date
NO993647D0 true NO993647D0 (no) 1999-07-27
NO993647L NO993647L (no) 1999-09-27
NO328460B1 NO328460B1 (no) 2010-02-22

Family

ID=18203488

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19993647A NO328460B1 (no) 1997-11-28 1999-07-27 Anvendelse av 15-keto-prostaglandin E-forbindelser til fremstilling av medikamenter

Country Status (17)

Country Link
US (1) US6197821B1 (no)
EP (1) EP0978284B1 (no)
JP (1) JP4319256B2 (no)
KR (1) KR100648868B1 (no)
CN (1) CN1206997C (no)
AT (1) ATE401894T1 (no)
AU (1) AU739343B2 (no)
CA (1) CA2279267C (no)
DE (1) DE69839767D1 (no)
DK (1) DK0978284T3 (no)
ES (1) ES2310013T3 (no)
HK (1) HK1025521A1 (no)
NO (1) NO328460B1 (no)
NZ (1) NZ336960A (no)
PT (1) PT978284E (no)
TW (1) TW592701B (no)
WO (1) WO1999027934A1 (no)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4786866B2 (ja) * 2001-08-31 2011-10-05 スキャンポ・アーゲー クロライドチャンネルオープナーとしてのプロスタグランジンアナログ
AR037524A1 (es) * 2001-11-14 2004-11-17 Sucampo Ag Unidad de dosificacion que comprende un analogo de prostaglandina para el tratamiento de la constipacion
US7732487B2 (en) 2001-11-19 2010-06-08 Sucampo Ag Method for treating a disease or condition responsive to opening of C1C-2 channel
EP1575596B1 (en) * 2002-12-27 2016-06-22 Sucampo AG Derivatives of prostaglandins for treating irritable bowel syndrome and/or functional dyspepsia
US20040225014A1 (en) * 2003-02-14 2004-11-11 Sucampo Ag Method for treating ocular hypertension and glaucoma
CN101146541B (zh) * 2005-01-27 2012-04-11 苏坎波公司 用于治疗中枢神经系统疾病的方法和组合物
CA2600331C (en) 2005-03-04 2014-07-08 Sucampo Ag Use of 11-deoxy-prostaglandin for treating peripheral vascular diseases
CA2819844C (en) * 2006-02-07 2015-09-15 R-Tech Ueno, Ltd. Prostaglandin derivatives
AR059636A1 (es) * 2006-02-28 2008-04-16 Sucampo Ag Metodo y composicion para tratar la enfermedad pulmonar obstructiva cronica
KR20080111137A (ko) * 2006-04-13 2008-12-22 액테리온 파마슈티칼 리미티드 초기 단계 특발성 폐 섬유증을 위한 엔도텔린 수용체 대항제
EP2114411A2 (en) * 2007-02-27 2009-11-11 Sucampo AG Composition and method for protecting mitochondria
US20090082442A1 (en) * 2007-09-26 2009-03-26 Protia, Llc Deuterium-enriched lubiprostone
CN102050808B (zh) * 2009-11-02 2014-03-12 上海天伟生物制药有限公司 一种前列腺素中间体的制备方法
EP2516412A4 (en) * 2009-12-18 2013-05-29 Apotex Pharmachem Inc PROCESS FOR CLEANING LUBIPROSTON
CN104557845B (zh) * 2015-01-13 2020-12-22 齐鲁制药有限公司 一种鲁比前列酮化合物的制备方法

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3853951A (en) 1971-07-14 1974-12-10 American Cyanamid Co Preparation of 9-oxo-13-trans-prostenoic acid esters by alanate addition to cyclopentenone
US4018811A (en) 1972-02-11 1977-04-19 American Cyanamid Company 3-Alkyl-2-(6-carboxyhexyl)cyclopentanones and esters and salts thereof
US3981868A (en) 1973-05-31 1976-09-21 American Cyanamid Company Derivatives of 9-oxo-13-trans-prostenoic acid amides
CA1323364C (en) * 1987-01-28 1993-10-19 Ryuzo Ueno Prostaglandins e and anti ulcer agents containing same
JP2597649B2 (ja) * 1988-05-11 1997-04-09 株式会社上野製薬応用研究所 気管・気管支拡張剤
US5362751A (en) 1988-05-11 1994-11-08 Kabushiki Kaisha Ueno Seiyaku Oyo Kenkyujo Tracheobronchodilator using 16-substituted PGEs
ES2055051T3 (es) * 1988-05-23 1994-08-16 Ueno Seiyaku Oyo Kenkyujo Kk Un metodo para la fabricacion de un medicamento eficaz para aumentar la presion sanguinea.
JPH0232031A (ja) * 1988-07-22 1990-02-01 Nippon Steel Chem Co Ltd イソプロピル化ｐ‐ターフェニル類の製造法
CA2027814C (en) * 1989-10-20 1996-07-30 Ryuji Ueno Treatment of hepatobiliary disease with 15-keto-prostaglandin compounds
CA2030344C (en) * 1989-11-22 2000-04-18 Ryuji Ueno Treatment of pulmonary dysfunction with 15-keto-prostaglandin compounds
CA2030346C (en) * 1989-11-22 2000-04-11 Ryuji Ueno Treatment of cardiac dysfunction with 15-keto-prostaglandin compounds
CA2030345C (en) * 1989-11-22 1998-12-08 Ryuji Ueno Use of 15-keto-prostaglandin compound for improvement of encephalic function
CA2039420C (en) * 1990-04-04 1996-12-10 Ryuji Ueno Treatment of cataract with 15-keto-prostaglandin compounds
ATE174221T1 (de) * 1990-05-01 1998-12-15 R Tech Ueno Ltd Behandlung von pankreaskrankheit mit 15-keto- prostaglandin e-derivaten
CA2046069C (en) * 1990-07-10 2002-04-09 Ryuji Ueno Treatment of inflammatory diseases with 15-keto-prostaglandin compounds
ES2093774T3 (es) * 1991-03-14 1997-01-01 R Tech Ueno Ltd Estimulacion de la curacion de heridas con un compuesto 15-cetoprostaglandina.
DK0857718T3 (da) 1996-06-10 2002-12-16 Sucampo Ag Endothelinantagonist
JPH107574A (ja) 1996-06-17 1998-01-13 R Tec Ueno:Kk エンドセリン拮抗剤

Also Published As

Publication number Publication date
JP4319256B2 (ja) 2009-08-26
TW592701B (en) 2004-06-21
US6197821B1 (en) 2001-03-06
DK0978284T3 (da) 2008-10-27
EP0978284A4 (en) 2001-07-18
KR100648868B1 (ko) 2006-11-24
NZ336960A (en) 2001-02-23
ATE401894T1 (de) 2008-08-15
CA2279267A1 (en) 1999-06-10
KR20000070508A (ko) 2000-11-25
WO1999027934A1 (fr) 1999-06-10
HK1025521A1 (en) 2000-11-17
CA2279267C (en) 2010-01-12
CN1206997C (zh) 2005-06-22
AU1053799A (en) 1999-06-16
DE69839767D1 (de) 2008-09-04
AU739343B2 (en) 2001-10-11
NO993647L (no) 1999-09-27
EP0978284A1 (en) 2000-02-09
PT978284E (pt) 2008-10-07
CN1251040A (zh) 2000-04-19
NO328460B1 (no) 2010-02-22
EP0978284B1 (en) 2008-07-23
ES2310013T3 (es) 2008-12-16

Similar Documents

Publication Publication Date Title
NO993647D0 (no) Endotelinantagonist
DK1489082T3 (da) Mellemprodukter
FR2768916B1 (fr) Agrafe d'osteotomie tibiale
EA200000381A1 (ru) Препарат 2-метил-тиено-бензодиазепина
FR09C0028I2 (fr) ANTAGONISTES DE GnRH MODIFIES AUX POSITIONS 5 ET 6
CY2007024I1 (el) Kαινοφανη παραγωγα 3.3-διαφαινυλοπροπυλινων
FR2704135B1 (fr) Agrafe d'osteosynthese.
TR199600029A2 (tr) 2,8-disübstitüe edilmis kinazolinonlar.
JP2000500874A5 (no)
JP2000507463A5 (no)
JP2000508937A5 (no)
ATE314387T1 (de) Dolastatin 15 derivate
JP2001500904A5 (no)
FR2750610B3 (fr) Palme constituee par la combinaison d'une botte, d'une chaussure, d'un soulier ou similaire avec une palme
TR199501132A2 (tr) Nörokinin karsitlari (antagonistleri).
FR2799148B3 (fr) Agrafeuse avec indication de la quantite d'agrafes restantes
ID28874A (id) Inhibitor fosfodiesterase 4 turunan ftalazina.
BR9804027A (pt) Novos beta-ceto ésteres
JP2000500662A5 (no)
TR199800988A3 (tr) 5' Deoksi-Sitidin türevleri.
DE69938258D1 (de) 4,5-pyrazinoxindole als proteinkinasehemmer
PT1119359E (pt) Formulacao de 2-metil-tieno-benzodiazepina
JP2000504647A5 (no)
IT1302243B1 (it) Sintesi dell'1,1,1,3,3-pentafluoropropano.
JP2000500664A5 (no)

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees